D
Dar Clinical Research Inc | Ottawa, Canada
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Ritlecitinib
Ruxolitinib
Parent organization
This site is a part of Dar Clinical Research Inc
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 2 total trials
The purpose of this study is to to evaluate the safety and efficacy of ruxolitinib cream in pediatric participants with nonsegmental vitiligo.
Enrolling
NonSegmental Vitiligo
Drug: Ruxolitinib Cream
Drug: Vehicle Cream
The purpose of the study is to learn about the safety and effects of the study medicine (called ritlecitinib) for the treatment of chronic spontaneou...
Enrolling
Chronic Spontaneous Urticaria
Drug: Placebo - 100 mg
Drug: Ritlecitinib 50 mg
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems